T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Evolution Petroleum
EPM
$177M
| $65K | ﹤0.01% |
+12,259
| New | +$65K |
|
2877
Tango Therapeutics
TNGX
$765M
| $65K | ﹤0.01% |
20,998
+4,813
| +30% | +$14.9K |
|
2878
Beam Global
BEEM
$46.2M
| $63K | ﹤0.01% |
19,600
| – | – |
|
2879
Perspective Therapeutics
CATX
$250M
| $63K | ﹤0.01% |
19,692
+1,784
| +10% | +$5.71K |
|
2880
Dakota Gold
DC
$510M
| $63K | ﹤0.01% |
28,317
+6,416
| +29% | +$14.3K |
|
2881
Destination XL Group
DXLG
$67.9M
| $63K | ﹤0.01% |
23,334
+7,020
| +43% | +$19K |
|
2882
Fate Therapeutics
FATE
$109M
| $63K | ﹤0.01% |
38,049
-27,170
| -42% | -$45K |
|
2883
AlTi Global
ALTI
$414M
| $61K | ﹤0.01% |
13,674
+2,807
| +26% | +$12.5K |
|
2884
FibroGen
FGEN
$46.5M
| $61K | ﹤0.01% |
4,640
-1,620
| -26% | -$21.3K |
|
2885
Larimar Therapeutics
LRMR
$328M
| $60K | ﹤0.01% |
15,452
+1,992
| +15% | +$7.74K |
|
2886
Nkarta
NKTX
$148M
| $60K | ﹤0.01% |
23,958
+7,030
| +42% | +$17.6K |
|
2887
Rackspace Technology
RXT
$342M
| $60K | ﹤0.01% |
26,807
+5,214
| +24% | +$11.7K |
|
2888
Gossamer Bio
GOSS
$630M
| $59K | ﹤0.01% |
64,777
-6,369,269
| -99% | -$5.8M |
|
|
HSHP
2889
Himalaya Shipping
HSHP
$384M
| $59K | ﹤0.01% |
+12,131
| New | +$59K |
|
2890
CS Disco
LAW
$353M
| $59K | ﹤0.01% |
+11,724
| New | +$59K |
|
2891
Puma Biotechnology
PBYI
$237M
| $59K | ﹤0.01% |
19,083
+5,726
| +43% | +$17.7K |
|
2892
Wheels Up
UP
$1.53B
| $59K | ﹤0.01% |
35,275
+6,422
| +22% | +$10.7K |
|
2893
ADC Therapeutics
ADCT
$369M
| $58K | ﹤0.01% |
28,831
| – | – |
|
|
WW
2894
DELISTED
WW International
WW
| $58K | ﹤0.01% |
45,100
| – | – |
|
2895
Lexicon Pharmaceuticals
LXRX
$400M
| $57K | ﹤0.01% |
77,502
-39,677
| -34% | -$29.2K |
|
|
AIRJW
2896
AirJoule Technologies Corporation Warrant
AIRJW
$44.1M
| $57K | ﹤0.01% |
56,154
| – | – |
|
|
QVCGA
2897
QVC Group, Inc. Series A Common Stock
QVCGA
$78.5M
| $57K | ﹤0.01% |
3,417
| – | – |
|
2898
Caribou Biosciences
CRBU
$168M
| $57K | ﹤0.01% |
35,848
+8,008
| +29% | +$12.7K |
|
2899
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $56K | ﹤0.01% |
40,169
| – | – |
|
2900
Editas Medicine
EDIT
$249M
| $56K | ﹤0.01% |
43,777
-21,041
| -32% | -$26.9K |
|